iSpecimen Inc. (NASDAQ:ISPC) Sees Large Increase in Short Interest

iSpecimen Inc. (NASDAQ:ISPC) saw a significant growth in short interest in the month of July. As of July 15th, there was short interest totalling 788,000 shares, a growth of 149.8% from the June 30th total of 315,400 shares. Approximately 7.9% of the shares of the company are sold short. Based on an average daily volume of 4,240,000 shares, the days-to-cover ratio is currently 0.2 days.

iSpecimen Stock Performance

Shares of ISPC stock traded up $0.00 during midday trading on Friday, hitting $0.29. 803,595 shares of the company were exchanged, compared to its average volume of 2,309,303. iSpecimen has a 52 week low of $0.20 and a 52 week high of $1.75. The firm has a market capitalization of $3.77 million, a P/E ratio of -0.22 and a beta of 1.60. The firm’s 50 day moving average price is $0.33 and its two-hundred day moving average price is $0.35.

iSpecimen (NASDAQ:ISPC) last issued its quarterly earnings data on Tuesday, May 7th. The company reported ($0.32) earnings per share (EPS) for the quarter. iSpecimen had a negative return on equity of 105.25% and a negative net margin of 124.84%. The firm had revenue of $2.29 million for the quarter.

About iSpecimen

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.